Evaluating the Efficacy of Biosimilar Infliximab with the ACR50 Response in Patients with Rheumatoid Arthritis; A Meta-Analysis in Bayesian Framework
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.1454
https://www.valueinhealthjournal.com/article/S1098-3015(13)03359-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1298
First Page :
A556
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03359-7&doi=10.1016/j.jval.2013.08.1454